These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7782708)

  • 1. Fear not science drives toxicologic risk assessment.
    Lehr J
    J Med Assoc Ga; 1995 May; 84(5):221-3. PubMed ID: 7782708
    [No Abstract]   [Full Text] [Related]  

  • 2. [Assessing the risk of disease upon exposure to systemic toxicants].
    Katul'skiĭ IuN
    Gig Sanit; 2001; (6):66-8. PubMed ID: 11810916
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxicology and the general practitioner.
    Spickett JT; Vosper ML
    Aust Fam Physician; 1995 Aug; 24(8):1442-5. PubMed ID: 7677612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporating biologically based models into assessments of risk from chemical contaminants.
    Bull RJ; Conolly RB; De Marini DM; MacPhail RC; Ohanian EV; Swenberg JA
    J Am Water Works Assoc; 1993 Mar; 85(3):49-52. PubMed ID: 11538064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Problems in prediction of toxicity and risk of effects of chemical substances on public health].
    Rumiantsev GI; Novikov SM
    Gig Sanit; 1997; (6):13-8. PubMed ID: 9483844
    [No Abstract]   [Full Text] [Related]  

  • 6. Future of toxicology--low-dose toxicology and risk--benefit analysis.
    Rietjens IM; Alink GM
    Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of in vitro toxicity data in hazard and risk assessment: current limitations and future perspectives.
    Blaauboer BJ
    Toxicol Lett; 2008 Aug; 180(2):81-4. PubMed ID: 18586419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory science. Panel pans proposed change in U.S. risk assessment.
    Charles D
    Science; 2007 Jan; 315(5810):316. PubMed ID: 17234922
    [No Abstract]   [Full Text] [Related]  

  • 9. Principles of risk assessment for determining the safety of chemicals: recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate.
    Hasegawa R; Koizumi M; Hirose A
    Congenit Anom (Kyoto); 2004 Jun; 44(2):51-9. PubMed ID: 15198717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Setting occupational exposure limits for pharmaceuticals.
    Naumann BD; Sargent EV
    Occup Med; 1997; 12(1):67-80. PubMed ID: 9153053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of endocrine-disrupting chemicals: critical overview and deficiencies in toxicology and risk assessment for human health.
    Harvey PW; Everett DJ
    Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):145-65. PubMed ID: 16522525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of the risk of exceeding the acceptable or tolerable daily intake.
    Renwick AG; Walker R
    Regul Toxicol Pharmacol; 1993 Dec; 18(3):463-80. PubMed ID: 8128007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of statistical values in plotting dose-effect relationships and determining the action thresholds of factors].
    Shandala MG; Antomonov MIu
    Gig Sanit; 1986 Jul; (7):26-8. PubMed ID: 3758702
    [No Abstract]   [Full Text] [Related]  

  • 14. Critical analysis of methods for assessment of predicted no-effect concentration.
    Roman G; Isnard P; Jouany J
    Ecotoxicol Environ Saf; 1999 Jun; 43(2):117-25. PubMed ID: 10375413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Putting chemicals on a path to better risk assessment.
    Stokstad E
    Science; 2009 Aug; 325(5941):694-5. PubMed ID: 19661414
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormesis: from marginalization to mainstream: a case for hormesis as the default dose-response model in risk assessment.
    Calabrese EJ
    Toxicol Appl Pharmacol; 2004 Jun; 197(2):125-36. PubMed ID: 15163548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of the risk assessment of hazardous materials and the role of toxicology.
    Mattie DR
    Ann Clin Lab Sci; 1997; 27(3):173-8. PubMed ID: 9142368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Introduction to toxicology: methods for the determination of toxicity of substances. II].
    Reith JF
    Pharm Weekbl; 1969 Oct; 104(44):1373-85. PubMed ID: 5352088
    [No Abstract]   [Full Text] [Related]  

  • 19. [Introduction to toxicology: methods for the determination of the toxicity of substances. I].
    Reith JF
    Pharm Weekbl; 1969 Oct; 104(41):1285-94. PubMed ID: 5362074
    [No Abstract]   [Full Text] [Related]  

  • 20. Confounders in interpreting pathology for safety and risk assessment.
    Wolf DC; Mann PC
    Toxicol Appl Pharmacol; 2005 Feb; 202(3):302-8. PubMed ID: 15667835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.